$130 Million is the total value of Bill & Melinda Gates Foundation's 9 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VIR | VIR BIOTECHNOLOGY INC | $39,700,000 | -1.0% | 1,559,142 | 0.0% | 30.52% | +41.5% | |
| CVAC | CUREVAC N V | $23,300,000 | -30.4% | 1,709,781 | 0.0% | 17.91% | -0.6% | |
| BNTX | BIONTECH SEsponsored ads | $22,200,000 | -12.6% | 148,674 | 0.0% | 17.06% | +25.0% | |
| IMCR | IMMUNCORE HLDGS PLCads | $21,500,000 | +25.0% | 576,923 | 0.0% | 16.53% | +78.7% | |
| EXSCIENTIAads | $17,300,000 | -24.5% | 1,590,909 | 0.0% | 13.30% | +8.0% | ||
| BFLY | BUTTERFLY NETWORK INC | $3,100,000 | -35.4% | 1,011,003 | 0.0% | 2.38% | -7.7% | |
| BCEL | ATRECA INC | $2,400,000 | -42.9% | 1,331,358 | 0.0% | 1.84% | -18.3% | |
| AMRS | AMYRIS INC | $500,000 | -61.5% | 292,398 | 0.0% | 0.38% | -45.1% | |
| ZY | ZYMERGEN INC | $100,000 | -50.0% | 59,970 | 0.0% | 0.08% | -28.7% | |
| Exit | SERA PROGNOSTICS INC | $0 | – | -799,814 | -100.0% | -1.61% | – | |
| Exit | LUMIRADX LIMITED | $0 | – | -5,574,059 | -100.0% | -17.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CUREVAC N V | 12 | Q3 2023 | 58.0% |
| VIR BIOTECHNOLOGY INC | 12 | Q3 2023 | 32.0% |
| BIONTECH SE | 12 | Q3 2023 | 35.8% |
| ATRECA INC | 12 | Q3 2023 | 5.3% |
| AMYRIS INC | 12 | Q3 2023 | 1.2% |
| IMMUNCORE HLDGS PLC | 11 | Q3 2023 | 35.7% |
| BUTTERFLY NETWORK INC | 11 | Q3 2023 | 3.8% |
| LUMIRADX LTD | 8 | Q3 2023 | 18.0% |
| EXSCIENTIA | 8 | Q3 2023 | 13.3% |
| ZYMERGEN INC | 6 | Q3 2022 | 0.3% |
View Bill & Melinda Gates Foundation's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LumiraDx Ltd | August 03, 2022 | 19,859,773 | 15.8% |
| Atreca, Inc. | February 16, 2021 | 1,396,644 | 4.7% |
| Liquidia Technologies Inc | February 12, 2020 | 119,678 | 0.5% |
| X4 Pharmaceuticals, Inc | March 15, 2019 | 120,363 | 1.8% |
| Arsanis, Inc. | February 13, 2018 | 722,179 | 5.1% |
View Bill & Melinda Gates Foundation's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| SC 13D | 2022-08-03 |
| SC 13G | 2022-07-15 |
| 13F-HR | 2022-05-13 |
View Bill & Melinda Gates Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.